Liminal Biosciences Inc. (LMNL) Social Stream

Featured Post From StockTwits About LMNL

$LMNL wow, another 10% drop. Not a word from Liminal management. They were quick to announce the cancellation of fez phase 2 trials on IPF etc and it’s taken another 2 months to figure out other biomarkers on liver, kidney and heart? Something is rotten here.